PeptiDream Inc.

OTCPK:PPTD.F Stock Report

Market Cap: US$2.2b

PeptiDream Past Earnings Performance

Past criteria checks 6/6

PeptiDream has been growing earnings at an average annual rate of 41.8%, while the Biotechs industry saw earnings growing at 22.1% annually. Revenues have been growing at an average rate of 43.1% per year. PeptiDream's return on equity is 29.3%, and it has net margins of 35.8%.

Key information

41.8%

Earnings growth rate

41.3%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth rate43.1%
Return on equity29.3%
Net Margin35.8%
Next Earnings Update13 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How PeptiDream makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:PPTD.F Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2447,77317,1157,7393,194
30 Jun 2455,41921,6897,0493,120
31 Mar 2427,9742,4416,8573,137
31 Dec 2328,7123,0356,6733,155
30 Sep 2338,18711,2816,9703,286
30 Jun 2331,2547,9566,8453,257
31 Mar 2331,3968,1356,8333,229
31 Dec 2226,8527,5545,8302,915
30 Sep 2212,811574,9441,888
30 Jun 2211,5111,7053,8621,164
31 Mar 228,3262,3412,759394
31 Dec 219,3663,6062,5900
30 Sep 2115,6077,1102,6930
30 Jun 2111,4494,3292,6230
31 Mar 2112,7435,2262,5270
31 Dec 2011,6774,4482,5380
31 Dec 192,075-9772,5060
30 Jun 197,2172,7701,9860
30 Jun 186,4272,3351,7370
31 Mar 184,6168951,7970
30 Sep 174,2719621,6470
30 Jun 174,8961,8911,0460
31 Mar 173,0647698260
31 Dec 164,4571,6857640
30 Sep 164,7351,8237390
30 Jun 164,3281,5816940
31 Mar 164,6201,9766030
31 Dec 153,1211,2034810
30 Sep 152,7221,0634090
30 Jun 152,4741,0043620
31 Mar 15757463100
31 Dec 14739673070
30 Sep 147861183010
30 Jun 148191493030

Quality Earnings: PPTD.F has high quality earnings.

Growing Profit Margin: PPTD.F's current net profit margins (35.8%) are higher than last year (29.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: PPTD.F's earnings have grown significantly by 41.8% per year over the past 5 years.

Accelerating Growth: PPTD.F's earnings growth over the past year (51.7%) exceeds its 5-year average (41.8% per year).

Earnings vs Industry: PPTD.F earnings growth over the past year (51.7%) exceeded the Biotechs industry 16.6%.

Return on Equity

High ROE: PPTD.F's Return on Equity (29.3%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 17:10
End of Day Share Price 2024/12/11 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PeptiDream Inc. is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hidemaru YamaguchiCitigroup Inc
Fumiyoshi SakaiCredit Suisse
Kazuaki HashiguchiDaiwa Securities Co. Ltd.